12 results on '"Hack, A. C."'
Search Results
2. Complementary medicine in radiation oncology: German health care professionals’ current qualifications and therapeutic methods
- Author
-
Kessel, Kerstin A., Klein, Evelyn, Hack, Carolin C., and Combs, Stephanie E.
- Published
- 2018
- Full Text
- View/download PDF
3. Breast cancer patients’ satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service
- Author
-
Hack, Carolin C., Antoniadis, Sophia, Hackl, Janina, Langemann, Hanna, Schwitulla, Judith, Fasching, Peter A., Beckmann, Matthias W., and Theuser, Anna-Katharin
- Published
- 2018
- Full Text
- View/download PDF
4. Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
- Author
-
Klein, Evelyn, Beckmann, Matthias W., Bader, Werner, Brucker, Cosima, Dobos, Gustav, Fischer, Dorothea, Hanf, Volker, Hasenburg, Annette, Jud, Sebastian M., Kalder, Matthias, Kiechle, Marion, Kümmel, Sherko, Müller, Andreas, Müller, Myrjam-Alice T., Paepke, Daniela, Rotmann, Andre-Robert, Schütz, Florian, Scharl, Anton, Voiss, Petra, Wallwiener, Markus, Witt, Claudia, and Hack, Carolin C.
- Published
- 2017
- Full Text
- View/download PDF
5. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network
- Author
-
Fremd, Carlo, Hack, Carolin C., Schneeweiss, Andreas, Rauch, Geraldine, Wallwiener, Diethelm, Brucker, Sara Yvonne, Taran, Florin-Andrei, Hartkopf, Andreas, Overkamp, Friedrich, Tesch, Hans, Fehm, Tanja, Hadji, Peyman, Janni, Wolfgang, Lüftner, Diana, Lux, Michael P., Müller, Volkmar, Ettl, Johannes, Belleville, Erik, Sohn, Christof, Schuetz, Florian, Beckmann, Matthias M., Fasching, Peter A., and Wallwiener, Markus
- Published
- 2017
- Full Text
- View/download PDF
6. Active Participation, Mind–Body Stabilization, and Coping Strategies with Integrative Medicine in Breast Cancer Patients
- Author
-
Theuser, Anna-Katharin, Antoniadis, Sophia, Langemann, Hanna, Wasner, Sonja, Grasruck, Katharina, Dietzel-Drentwett, Svenja, Fasching, Peter A., Beckmann, Matthias W., and Hack, Carolin C.
- Subjects
integrative medicine ,Breast Neoplasms ,active participation ,coping ,breast cancer ,Cross-Sectional Studies ,Cancer Survivors ,mind–body ,oncology ,Adaptation, Psychological ,Humans ,Female ,ddc:610 ,Research Article ,complementary and alternative medicine - Abstract
Purpose: Increasing numbers of breast cancer survivors have led to a growing demand for integrative medicine. When patients have completed treatments associated with severe side effects, attention turns to reducing psychological symptoms, coping behavior, and self-care. The aim of this study was to assess patient-reported benefits in relation to active participation, mind–body stabilization, and coping strategies in breast cancer patients receiving integrative medicine. Methods: In a cross-sectional study, health counseling and treatment provided by a standardized integrative medicine consultancy service at the University Breast Center of Franconia were evaluated in 75 breast cancer patients over a 15-month period. At the baseline, the patients answered a questionnaire on their medical history, symptoms, and the treatment goals they were hoping to achieve with integrative medicine. Patient-reported outcomes relative to active participation, mind–body stabilization, and coping strategies were analyzed. Results: A large majority of the patients had previous experience with integrative medicine (91%). Most reported that they achieved their treatment goals with integrative medicine. Ninety-one percent achieved active participation in cancer treatment, 90% mind–body stabilization, and 79% improvement in coping strategies. Besides active participation, which was greatest in patients with stable disease, the success of integrative therapy was independent of age, concomitant diseases, previous integrative medicine experience, treatment state, and systemic cancer therapy. Conclusion: Breast cancer patients benefit from the counseling and treatment provided with integrative medicine in mind–body stabilization and coping with cancer. Active participation in cancer treatment is important for the patients. Integrative treatment services should form part of routine patient care.
- Published
- 2021
7. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
- Author
-
Hack, Carolin C., Häberle, Lothar, Brucker, Sara Y., Janni, Wolfgang J., Volz, Bernhard, Loehberg, Christian R., Hartkopf, Andreas Daniel, Walter, Christina-Barbara, Baake, Gerold, Fridman, Alexander, Malter, Wolfram, Wuerstlein, Rachel, Harbeck, Nadia, Hoffmann, Oliver, Kuemmel, Sherko, Martin, Bernhard, Thomssen, Christoph, Graf, Heiko, Wolf, Christopher, Lux, Michael P., Bayer, Christian Michael, Rauh, Claudia, Almstedt, Katrin, Gaß, Paul, Heindl, Felix, Brodkorb, Tobias Franz, Willer, L., Lindner, C., Kolberg, Hans Christian, Krabisch, Petra, Weigel, Michael, Steinfeld-Birg, Dieter, Kohls, Andreas, Brucker, Cosima, Schulz, Volker, Fischer, Gunnar, Pelzer, Volker, Rack, Brigitte K., Beckmann, Matthias Wilhelm, Fehm, Tanja Natascha, Rody, Achim R., Maass, Nicolai, Hein, Alexander, Fasching, Peter Andreas, and Nabieva, Naiba
- Subjects
Complementary Therapies ,Aromatase Inhibitors ,Medizin ,Breast Neoplasms ,Myalgia ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Arthralgia ,Postmenopause ,Breast cancer ,Complementary and alternative medicine ,Medizinische Fakultät ,Musculoskeletal Pain ,Germany ,Letrozole ,Humans ,Female ,Original Article ,ddc:610 ,Integrative medicine ,Endocrine therapy/treatment ,Aged - Abstract
Background Patients with breast cancer (BC) show strong interest in complementary and alternative medicine (CAM), particularly for adverse effects of adjuvant endocrine treatment — e.g., with letrozole. Letrozole often induces myalgia/limb pain and arthralgia, with potential noncompliance and treatment termination. This analysis investigated whether CAM before aromatase inhibitor (AI) therapy is associated with pain development and the intensity of AI-induced musculoskeletal syndrome (AIMSS) during the first year of treatment. Patients and methods The multicenter phase IV PreFace study evaluated letrozole therapy in postmenopausal, hormone receptor–positive patients with early BC. Patients were asked about CAM use before, 6 months after, and 12 months after treatment started. They recorded pain every month for 1 year in a diary including questions about pain and numeric pain rating scales. Data were analyzed for patients who provided pain information for all time points. Results Of 1396 patients included, 901 (64.5%) had used CAM before AI treatment. Throughout the observation period, patients with CAM before AI treatment had higher pain values, for both myalgia/limb pain and arthralgia, than non-users. Pain increased significantly in both groups over time, with the largest increase during the first 6 months. No significant difference of pain increase was noted regarding CAM use. Conclusions CAM use does not prevent or improve the development of AIMSS. Pain intensity was generally greater in the CAM group. Therefore, because of the risk of non-compliance and treatment discontinuation due to the development of higher pain levels, special attention must be paid to patient education and aftercare in these patients., Highlights • Pain levels of myalgia/limb pain and arthralgia increase under letrozole intake. • Within one year pain levels increase in both, CAM users as well as non-CAM users. • In CAM users pain levels were higher at all time points than in non-CAM users. • The greatest increase of pain levels was noted in the first six treatment months. • CAM does not prevent or improve the development of myalgia/limb pain and arthralgia.
- Published
- 2020
8. Komplementärmedizin in der Radioonkologie : Aktuelle Qualifikationen und Therapiemethoden deutscher medizinischer Fachkräfte.
- Author
-
Kessel, Kerstin A., Klein, Evelyn, Hack, Carolin C., and Combs, Stephanie E.
- Subjects
ALTERNATIVE medicine ,CLINICAL competence ,COMBINED modality therapy ,FEMALE reproductive organ tumors ,MEDICAL protocols ,ONCOLOGY ,QUALITY of life ,RADIOTHERAPY ,CONTINUING medical education ,INTEGRATIVE medicine - Abstract
Introduction: Recently, complementary and alternative medicine (CAM) has moved more into the focus, and cancer societies such as the German Cancer Society (Deutsche Krebsgesellschaft, DKG) have established working groups to develop a guideline for CAM. The present work aims to evaluate the acceptance of CAM in the whole radiation oncology community.Methods: We conducted an online survey on CAM and sent the modified questionnaire that was successfully distributed to all members of the Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynakologische Onkologie, AGO) of the DKG in 2014 to the members of the German Society of Radiation Oncology (Deutsche Gesellschaft für Radioonkologie und Strahlentherapie, DEGRO). The survey consisted of 17 questions regarding personal information and current CAM guidelines within the workplace/clinic.Results: A total of 143 members participated. Of these, 12% had some CAM qualification. For hematological cancer in 35% and in up to 76% for breast cancer, CAM treatment is offered in German radiation oncology facilities, mainly due to fatigue symptoms. CAM is part of routine treatment in 32.2%, 22.0% are planning to incorporate it. Most physicians advise patients to partake in sports activities and recommend dietary supplements and nutritional counseling. The cost of CAM treatment is fully covered in 9.8% of all participating facilities.Conclusion: Today, CAM is integrated into cancer care; however, skepticism regarding its effect still exists. Evidence-based results must be generated to convince physicians of the effectiveness of CAM methods. CAM qualifications must be included in physicians' training to improve their understanding and counseling regarding CAM options in cancer care. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
9. Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.
- Author
-
Hack, Carolin C., Hackl, Janina, Hüttner, Nina B. M., Langemann, Hanna, Schwitulla, Judith, Dietzel-Drentwett, Svenja, Fasching, Peter A., Beckmann, Matthias W., and Theuser, Anna-Katharin
- Abstract
Purpose. Although the demand from patients for integrative medicine is increasing, complementary medicine services are still quite heterogeneous and have not been incorporated into clinical routine. The aim of this study was to systematically evaluate improvements in side effects and quality of life associated with a hospital-based integrative medicine program in the modern breast cancer patient care setting. Methods. In a cross-sectional study, integrative health counseling and treatment were evaluated in women with breast cancer. Over a 15-month period, data for 75 patients from an integrative medicine consultancy service with standardized operating procedures were collected at the University Breast Center for Franconia. At baseline, the patients answered a questionnaire on their medical history, symptoms, and the treatment goals they were hoping to achieve with integrative medicine. In the follow-up, patient-reported outcomes related to side effects of conventional cancer treatment and patients’ quality of life were analyzed. Results. Among 60 patients with the therapy goal of reducing the side effects of conventional treatment, 46 (76.7%) were successful. Among 57 patients hoping to improve disease-related quality of life, 46 (82%) reported success. Whereas patients with metastatic disease achieved a reduction in the side effects of conventional therapy, quality-of-life improvements were predominantly achieved by patients with a good treatment prognosis. Conclusions. Breast cancer patients benefit from the counseling and treatment provided with integrative medicine in all phases of tumor disease. Integrative treatment services should be included as part of patient care in clinical routine work to offer patients the maximum quality of care and safety with complementary therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study.
- Author
-
Hack, Carolin C., Fasching, Peter A., Fehm, Tanja, de Waal, Johann, Rezai, Mahdi, Baier, Bernd, Baake, Gerold, Kolberg, Hans-Christian, Guggenberger, Martin, Warm, Mathias, Harbeck, Nadia, Wuerstlein, Rachel, Deuker, Jörg-Uwe, Dall, Peter, Richter, Barbara, Wachsmann, Grischa, Brucker, Cosima, Siebers, Jan W., Fersis, Nikos, and Kuhn, Thomas
- Abstract
Background. Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast cancer patients. A large prospective study was therefore conducted within a noninterventional study in order to identify the characteristics of patients interested in integrative medicine. Methods. The EvAluate-TM study is a prospective, multicenter noninterventional study in which treatment with the aromatase inhibitor letrozole was evaluated in postmenopausal women with hormone receptor–positive primary breast cancer. Between 2008 and 2009, 5045 postmenopausal patients were enrolled at 339 certified breast centers in Germany. As part of the data collection process, patients were asked at the baseline about their interest in and information needs relating to integrative medicine. Results. Of the 5045 patients recruited, 3411 responded to the questionnaire on integrative medicine and took part in the analysis, 1583 patients expressed an interest in integrative medicine, and 1828 patients declared no interest. Relevant predictors of interest in integrative medicine were age, body mass index, tumor size, previous chemotherapy, and use of concomitant medications for other medical conditions. Interest in integrative medicine declined highly significantly (P < .001) with age (<50 years, 74.1%; 50-60 years, 54.1%; >65 years, 38.0%). Patients in favor of integrative medicine were significantly less satisfied with the information received about individual treatments and antihormonal therapy. Patients with interest in integrative medicine were more often interested in rehabilitation and fitness, nutritional counseling, and additional support from self-help organizations. These women were mostly interested in receiving information about their disease and integrative medicine from a physician, rather than from other sources. Conclusions. This study shows that a considerable proportion of postmenopausal breast cancer patients are interested in integrative medicine. Information about integrative medicine should therefore be provided as part of patient care for this group. It was found that receiving concomitant medication for other medical conditions is one of the main predictors for women not being interested in integrative medicine. This group of patients may need special attention and individualized information about integrative medicine. Additionally, most patients were interested in obtaining the relevant information from their doctor. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Correction to: Breast cancer patients' satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service.
- Author
-
Hack, Carolin C., Antoniadis, Sophia, Hackl, Janina, Langemann, Hanna, Schwitulla, Judith, Fasching, Peter A., Beckmann, Matthias W., and Theuser, Anna-Katharin
- Subjects
- *
BREAST cancer patients , *CANCER treatment , *INTEGRATIVE medicine - Abstract
In the original version of this article contained an error in figure 1. It was provided in German. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
12. Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
- Author
-
D. Fischer, Andre-Robert Rotmann, Sebastian M. Jud, Andreas Müller, Gustav Dobos, W. Bader, Florian Schütz, Matthias W. Beckmann, Anton Scharl, Annette Hasenburg, Volker Hanf, Matthias Kalder, Marion Kiechle, Petra Voiss, Markus Wallwiener, Claudia M. Witt, Evelyn Klein, Sherko Kümmel, Daniela Paepke, Myrjam-Alice T. Müller, Carolin C. Hack, C Brucker, University of Zurich, and Hack, Carolin C
- Subjects
medicine.medical_specialty ,Attitude of Health Personnel ,Medizin ,Acupuncture Therapy ,Breast Neoplasms ,610 Medicine & health ,Gynecologic oncology ,Medical Oncology ,Oncologists’ attitudes ,03 medical and health sciences ,Breast cancer ,0302 clinical medicine ,Clinical work ,Surveys and Questionnaires ,Acupuncture ,Humans ,Medicine ,Medical nutrition therapy ,Integrative medicine ,Survey ,Oncologists ,Ovarian Neoplasms ,Gynecological oncology ,030219 obstetrics & reproductive medicine ,business.industry ,Obstetrics and Gynecology ,2729 Obstetrics and Gynecology ,General Medicine ,medicine.disease ,Popularity ,Exercise Therapy ,10034 Institute of Complementary Medicine ,030220 oncology & carcinogenesis ,Family medicine ,Dietary Supplements ,Female ,business ,Complementary medicine - Abstract
Purpose: The growing popularity and acceptance of integrative medicine is evident both among patients and among the oncologists treating them. As little data are available regarding health-care professionals’ knowledge, attitudes, and practices relating to the topic, a nationwide online survey was designed. Methods: Over a period of 11 weeks (from July 15 to September 30, 2014) a self-administered, 17-item online survey was sent to all 676 members of the Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynäkologische Onkologie) in the German Cancer Society. The questionnaire items addressed the use of integrative therapy methods, fields of indications for them, advice services provided, level of specific qualifications, and other topics. Results: Of the 104 respondents (15.4%) using integrative medicine, 93% reported that integrative therapy was offered to breast cancer patients. The second most frequent type of tumor in connection with which integrative therapy methods were recommended was ovarian cancer, at 80% of the participants using integrative medicine. Exercise, nutritional therapy, dietary supplements, herbal medicines, and acupuncture were the methods the patients were most commonly advised to use. Conclusion: There is considerable interest in integrative medicine among gynecological oncologists, but integrative therapy approaches are at present poorly implemented in routine clinical work. Furthermore there is a lack of specific training. Whether future efforts should focus on extending counseling services on integrative medicine approaches in gynecologic oncology or not, have to be discussed. Evidence-based training on integrative medicine should be implemented in order to safely guide patients in their wish to do something by themselves.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.